11 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
in Genentech, Inc.’s DNA Synthesis Group from 1986 until 1990. During his 28-year tenure at Gilead, Dr. Bischofberger presided over the development
8-K
VIR
Vir Biotechnology Inc
7 Apr 22
Departure of Directors or Certain Officers
4:06pm
&L and working on global commercial aspects of the business including strategy, planning and execution. During her more than 20-year tenure at Biogen
8-K
EX-3.2
oeqqult3
16 Oct 19
Departure of Directors or Certain Officers
4:01pm
S-1
EX-10.42
1uvglvgdmzn21doc7u53
3 Sep 19
IPO registration
4:40pm
S-1
EX-3.4
ko5 g9s04g4r1us8a
3 Sep 19
IPO registration
4:40pm
DRS
EX-10.42
rlr21q3l ec
27 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next